Takeaways from #AHA2024. Late breaking trials - take home points AHA Science   1. BPROAD Trial: Intensive treatment targeting SBP ≤120 mmHg reduced the incidence of MACE at 5 years vs. standard treatment targeting ≤140 mmHg in patients with type 2 diabetes and hypertension with

The Most Significant Updates in Electrophysiology in 2024 hmpgloballearningnetwork.com/site/eplab/let…

What a great accomplishment, thank you

Do you really wonder the best GP mapping strategy so far A combination of EGM characteristics by Ensite X Abbott Abbott and anatomy by inHEART This is just a trailer Just follow our live case in #EHRA2025 European Society of Cardiology EHRAPresident Serge Boveda

beckershospitalreview.com/rankings-and-r…

Impulse Dynamics is proud to announce that we have received European CE Mark approval for an expanded indication for the Optimizer® Smart Mini system, which delivers the company’s proprietary CCM® therapy! Read more here: news.impulse-dynamics.com/impulse-dynami…

The ICM monitored Phase 2 of ADVANTAGE AF met safety and efficacy endpoints and supports the relationship of AF burden and HCU #CircatHRS25 @ed_gerst Atul Verma @drjasonandrade Dr. Devi G Nair Anish Amin Ziad F. Issa Vivek Y. Reddy ahajrnls.org/42QqpG9

Congratulations to Dr Andrea Natale, the recipient of the 2025 Wilton Wells Webster Lectureship! #HRS2025 Amazing to hear his incredible body of work in relation to atrial fibrillation ablation. #EPeeps

Amin Al-Ahmad, MD shares early insights in PFA adoption in the US from the #DISRUPTAF registry at #HRS2025 He reports distinct workflow differences from previously reported European data like higher use of GA and EAM. Jose Osorio Paul Zei Mike Manogue

Roderick Tung Andre d’Avila jacc.org/doi/10.1016/j.…

Dr. Varma just delivered the presentation, “Novel Implantable Cardioverter-Defibrillator Platform with HF Therapy: Cardiac Contractility Modulation with Defibrillation”, at #HRS2025 showing the latest in the INTEGRA-D clinical trial and key findings. More to come—stay tuned!

#HRS2025 #JACCCEP LBCT: In the largest multicenter CNA experience to date, acceleration of baseline heart rate and a significant reduction in syncope burden were achieved with an acceptable rate of major procedural complications. jacc.org/doi/10.1016/j.…

CNA is exciting.

Terrific Rutgers NJMS Division of Cardiology Grand Rounds by Brittany Weber on #CardioRheum - Identifying and Treating Cardiovascular Disease in Immune-Mediated Inflammatory Conditions 👉key takeaways: 🚫#inflammation 🛠️#YesCCT #WhyCMR #ThinkPET The future is bright in this emerging field. Rutgers NJMS Cardiology Fellowship

🗣️ “Patients with low EF at risk of sudden death have a class I indication for an ICD, but those ICDs don’t treat HF, apart from the ones equipped with CRT,” Niraj Varma, MA, MD, PhD, FRCP, of Cleveland Clinic Heart, Vascular & Thoracic told Healio. #HRS2025 #cardiotwitter healio.com/news/cardiolog…

#EHRAtopicweek 🚨 Planning #TTVI? Consider the lead Transvenous lead extraction can reduce device-valve interference—but at a cost: 🔸 TR risk ↑ (up to 15%) 🔸 Dwell time >10y = ↑ complications 🔸 Careful imaging & team discussion = 🔑 🔧 #TLE is safer than ever—but not

#EHRAtopicweek on the State of the art of AI in EP Don’t miss the State of the art of AI in EP - A Scientific Statement of the #EHRA_ESC Heart Rhythm Society and European Society of Cardiology Working Group on E-cardiology, published in Europace Editor-in-Chief 🔗bit.ly/46zGzal Emma Svennberg David Duncker

Pretty open window AP map.